Agape ATP Corporation (ATPC) 股票分析

公司概述

Agape ATP Corporation operates primarily as an investment holding company focused on the Malaysian market, where it supplies a range of health and wellness products alongside health solution advisory services. The company's operational scope is diversified across two distinct segments: skin care and health and wellness, as well as green energy solutions. In terms of scale, the entity is a micro-cap stock with a total market capitalization of $2.71 million and an annual revenue (TTM) of $1.48 million, supported by a workforce of 16 employees. These valuation and revenue figures indicate that the company is a very small-scale enterprise within the Consumer Defensive sector, specifically the Packaged Foods industry, suggesting limited market penetration and a highly specialized niche operation rather than a broad consumer staple leader.

财务健康

The company reported a total revenue of $1.48 million over the trailing twelve months, yet this generated a net loss of $2,711,293, revealing a cost structure where operating expenses significantly exceeded gross profit generation. The EBITDA figure for the same period stood at -$2,724,867, indicating that the business operations themselves were cash-burning before financing costs and taxes. Free cash flow was negative at -$1,193,122, which implies a lack of financial flexibility and an inability to fund operations or capital expenditures from internal cash flows without external support. Despite these losses, the company holds a substantial cash reserve of $23.13 million, which contrasts sharply with its total debt obligation of only $247,807. The debt-to-equity ratio of 1.09 suggests a leveraged balance sheet relative to shareholder equity, yet the massive cash buffer mitigates immediate solvency risks. Liquidity is exceptionally strong, evidenced by a current ratio of 16.21, indicating that the company possesses more than sixteen times the current assets necessary to cover its short-term liabilities. Return on Equity stands at -21.6% and Return on Assets is -12.4%, metrics that reveal that management effectiveness has been negative, as the company is currently eroding shareholder and asset value rather than generating returns on the capital deployed.

估值评估

The trailing P/E ratio and forward P/E ratio are both listed as N/A due to the company's negative earnings and lack of projected profitability in the current model. Consequently, traditional price-to-earnings multiples cannot be calculated, forcing reliance on alternative valuation metrics to assess the stock's theoretical value. The price-to-book ratio is 0.12, indicating that the market values the company at roughly 12% of its book value, which suggests the market perceives significant intangible risks or potential distress rather than a premium over net assets. Alternative valuation multiples show a Price to Sales ratio of 1.83 and an EV/EBITDA of 7.42; however, given the negative earnings, these metrics should be interpreted with extreme caution as they do not reflect traditional profitability-based valuations. Regarding trading range, the 52-week high is $128.25 and the 52-week low is $1.72, a range of over $126 that highlights extreme price volatility and a potential gap in liquidity or trading interest. The current price sits significantly below the 52-week high, reflecting a market that has priced out the stock from its recent peak, while the beta of 0.04 indicates that the stock price exhibits almost no volatility relative to the broader market movements.

Growth & Income

Revenue growth year-over-year is recorded at 11.9%, demonstrating an expansion in top-line sales despite the persistent net losses reported in the financial statements. Earnings growth is listed as N/A because the company has not yet achieved profitability, meaning earnings cannot be compared directly to revenue growth to determine efficiency improvements. As a non-dividend payer, the company offers a dividend yield of N/A and maintains a payout ratio of 0.0%, indicating that any generated cash or retained earnings are currently being reinvested into the business or used to service the existing debt rather than distributed to shareholders. This reinvestment strategy is typical for early-stage or turnaround companies attempting to stabilize operations before returning capital to investors. The overall growth and income profile is characterized by top-line expansion coupled with structural losses and an absence of dividend income, presenting a high-risk, high-potential-reward scenario dependent on future operational turnarounds.